Physician profile
Lori Boyd
NPI 1952387623
$435.93
in general payments reported to CMS, 2019-2025
10 companies · $29.05 in 2025
The $29.05 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.67 · 2020: $109 · 2021: $38.87 · 2022: $100 · 2023: $73.65 · 2024: $43.86 · 2025: $29.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $158.88 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $54.92 | 2021-2024 | Precision 1 |
| Carl Zeiss Meditec, INC. | $45.78 | 2020 | |
| Horizon Therapeutics Plc | $43.95 | 2022-2023 | Tepezza |
| Abbvie INC. | $42.36 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $25.54 | 2019-2020 | |
| Optos, INC. | $18.23 | 2020 | |
| Bausch & Lomb Americas INC. | $16.02 | 2023 | Infuse |
| Tarsus Pharmaceuticals, INC. | $15.30 | 2024 | Xdemvy |
| Biotissue Holdings INC. | $14.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.